Patient with generalized melanoma treated with nivolumab with long-term response after previous failure of combined chemotherapy
MUDr. Taťána Šuková
Dermatovenerologická klinika VFN a 1. LF UK, Praha
Treatment of advances malignant melanoma has seen significant changes in recent years. After decades of stagnation when chemotherapy was used to treat metastatic melanoma the efficacy of which is limited in this tumor, two new drug regimens are now available - advanced imunotherapy offer the chance of long-term survival of nearly 30% of patients.
melanoma, modern imunotherapy, nivolumab
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...